Other languages ACADIA Pharmaceuticals Inc.

Equities

ACAD

US0042251084

Real-time Estimate Cboe BZX Other stock markets 01:41:16 2024-04-18 pm EDT			5-day change	1st Jan Change
17.09 ^USD	-0.58%		-2.07%	-45.54%

Apr. 17	ACADIA Pharmaceuticals Inc. Presents New DAYBUE (trofinetide) Clinical Data at the 2024 American Academy of Neurology Annual Meeting	CI
Apr. 02	ACADIA Pharmaceuticals Inc. Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive Vice President, Head of Research and Development	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ACADIA Pharmaceuticals Inc. Presents New DAYBUE (trofinetide) Clinical Data at the 2024 American Academy of Neurology Annual Meeting	Apr. 17
ACADIA Pharmaceuticals Inc. Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive Vice President, Head of Research and Development	Apr. 02
Acadia Pharmaceuticals Insider Sold Shares Worth $317,081, According to a Recent SEC Filing	Mar. 28
Sector Update: Health Care Stocks Gain Premarket Tuesday	Mar. 12
Aktien New York Ausblick: Gewinne erwartet nach Inflationsdaten	Mar. 12
Consumer Prices Tick Higher in February as US Equity Futures Turn Mixed Pre-Bell	Mar. 12
Top Premarket Decliners	Mar. 12
Acadia Pharmaceuticals Shares Fall After Late Study of Schizophrenia Drug Fails, Development Ends	Mar. 11
Acadia Pharmaceuticals' schizophrenia drug fails in late-stage study	Mar. 11
Acadia Pharmaceuticals Inc. Announces Top-Line Results from Phase 3 ADVANCE-2 Trial of Pimavanserin in Negative Symptoms of Schizophrenia	Mar. 11
Acadia Pharmaceuticals Q4 Swings to Profit, Revenue Increases -- Shares Fall After Hours	Feb. 27
ACADIA Pharmaceuticals Inc. Provides Sales Guidance for the Full Year 2024	Feb. 27
ACADIA Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27
ACADIA Pharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 27
Culper Research discloses short position in Acadia Pharma	Feb. 15
Acadia Pharmaceuticals Inc. Announces Executive Changes	Jan. 31
Acadia Pharmaceuticals Inc. Announces Management Changes	Jan. 30
Sector Update: Health Care	Dec. 13
Sector Update: Health Care Stocks Stronger Late Afternoon	Dec. 13
Acadia Pharmaceuticals Shares Rise After Winning Summary Judgment in Nuplazid Patent Case	Dec. 13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages ACADIA Pharmaceuticals Inc.

Equities

ACAD

US0042251084

Other languages

Filters